MARKET ANALYSIS, TRENDS, AND FORECASTS, MAY 2ġ. The report profiles 42 companies including many key and niche players such as: Multicenter human clinical studies of patients undergoing anterior lumbar fusion have been conducted using recombinant bone morphogenetic protein or rhBMP-2 on an absorbable collagen sponge, marketed as INFUSE Bone Graft, or autograft implanted in the LT-CAGE Lumbar Tapered Fusion device. It has 3 components: recombinant human bone. One of the functions of the protein is to stimulate bone. Infuse is a synthetic bone graft system indicated for spinal fusion available from Medtronic. INFUSE Bone Graft is recombinant human bone morphogenetic protein-2 (rhBMP-2) applied to an absorbable collagen sponge (ACS) carrier that localizes the rhBMP-2 at the site of implantation and resorbs over time. Company profiles are primarily based on public domain information including company URLs. (1) Package of 4 sterile absorbable collagen sponges (ACS) 1' x 2'. Medtronic Infuse is a bioengineered bone morphogenetic protein (BMP), which is used to encourage bone growth and replace spinal disks by filling the gaps. The INFUSE Bone Graft is considered medically necessary for treating skeletally mature persons with acute, open tibial shaft fractures that have been stabilized.
Market data and analytics are derived from primary and secondary research.
Also, a five-year historic analysis is provided for these markets. Infuse Bone Graft is a bone morphogenetic protein (BMP) graft which stimulates the growth of bone in places, such as the jaw, that have little bone density. (rhBMP-2, known as dibotermin alfa) placed on an absorbable collagen sponge. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World.Īnnual estimates and forecasts are provided for the period 2016 through 2024. INFUSE Bone Graft consists of recombinant human Bone Morphogenetic Protein-2. The US market is additionally analyzed by the following Segments: Demineralized Bone Matrix, Bone Morphogenetic Protein, Stem Cell Based Bone Grafts, and Synthetic Bone Grafts. 87.This report analyzes the worldwide markets for Bone Graft Substitutes in US$ Million. In addition, our attorneys provide each client with personalized attention and passionate representation.įREE consultation.
#Infuse bone graft full#
If you were implanted with a Medtronic Infuse Bone Graft, it is important to hire an experienced and skilled personal injury law firm to protect you and help you obtain the financial compensation you deserve.Īt PKSD, our experienced attorneys conduct a full investigation into your injuries and work to obtain high settlements for our clients. Roughly 75 percent of those patients suffer from side-effects such as:Ĭontact our Wisconsin Medtronic Infuse Bone Graft Lawyers In 2002, the FDA approved the Medtronic Infuse Bone Graft for limited use in lumbar, oral, and dental procedures, such as treating degenerative disc disease. At the time of biopsy, the bone formed by Infuse Bone Graft was mature, primarily lamellar bone.
Autogenous bone graft induced viable bone but the bone quality of the core samples was variable and included nonviable bone. Federal health statistics show that Infuse is used off-label 85 percent of the time.Īpproximately 100,000 patients undergoing spine surgery have been implanted with Infuse. Infuse Bone Graft induces new, mature, viable bone with a rich vascular marrow space. Infuse, a bone graft by Medtronic that has been used in cervical spinal fusions to stimulate bone growth, has caused serious health problems due to. The Medtronic Infuse bone graft system is used in neck and spinal surgeries to help promote bone growth. It was approved by the FDA in 2002, only for one kind of spine surgery that being an anterior approach lumbar fusion.Īny other use is considered off-label and a physician would have to fully disclose the risks of such use to the patient. INFUSE Bone Graft by Medtronic contains a bone growth protein used in an Anterior Lumbar Interbody Fusion (ALIF) procedure in combination with a metallic. The bone graft consists of bio-engineered liquid bone protein that encourages bone growth housed in a small container or cage that is implanted into the spine. This cylinder is where the genetically engineered material called. The InFUSE bone graft was approved by the FDA in 2002 for surgery on the lower parts of the spine. The Infuse Bone Graft uses the LT-Cage Device which consists of a small hollow metal cylinder. It was developed as an alternative to traditional bone grafting that involved painful bone harvesting from other areas of the body. Injuries Related to Medtronic InFUSE Bone Grafts. Medtronic developed a device to stimulate bone growth after lumbar spine surgery.
0 kommentar(er)
